Photo: Tom Williams/CQ-Roll Call, Inc via Getty Imag In a major blow to national vaccination efforts, the FDA and CDC recommended suspending the use of Johnson & Johnson's one-shot COVID vaccine because at least six people had developed severe blood clots after receiving it. The affected vaccine recipients were all between the ages of 18 and 48, with the clots showing up 6 to 13 days after immunization. One woman died, and one is in critical condition. The agencies will investigate whether the issue is more widespread, but for now at least, those who suffered a poor reaction represent a miniscule percentage of the near 7 million Americans who have received the shot. The government's decision immediately set off a debate about the wisdom of halting a vaccine's usage over what appears to be such a rare reaction. In a joint statement , the FDA and CDC said that "Right now, these adverse events appear to be extremely rare," but that "We are recommending a pause in the use of this vaccine out of an abundance of caution." In its own statement, Johnson & Johnson said, "At present, no clear causal relationship has been established between these rare events and… Read full this story
- HPV Vaccine Safe, But May Raise Risk of Fainting & Infections
- Samoa recalls vaccines, orders full investigation after two baby deaths
- Man, 43, suffered deadly ‘feather duvet lung’ after severe allergic reaction
- Just How Safe Are Vaccines? Here Are the Numbers
- The future of treatment for glioblastoma
- Why can’t we cure the common cold?
- Illinois doctors are recorded plotting to use policy loophole to seize newborns of parents who refused vitamin K shots and inject them by flagging their families for 'medical neglect'
- Snake bite: What to do, what not to do and why
- Are you an unvaccinated adult? Here's what you need to know about catching up
- Mum loses her arm to flesh-eating bug that ‘ate away’ at her body and triggered sepsis
U.S. to Pause J&J Vaccine Rollout After Rare Blood-Clot Reaction have 325 words, post on nymag.com at April 13, 2021. This is cached page on CuBird. If you want remove this page, please contact us.